238 related articles for article (PubMed ID: 16247788)
1. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
[TBL] [Abstract][Full Text] [Related]
2. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
4. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functioning in breast cancer survivors: a controlled comparison.
Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
[TBL] [Abstract][Full Text] [Related]
6. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
9. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
11. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
van Dam FS; Schagen SB; Muller MJ; Boogerd W; vd Wall E; Droogleever Fortuyn ME; Rodenhuis S
J Natl Cancer Inst; 1998 Feb; 90(3):210-8. PubMed ID: 9462678
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
14. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.
Noal S; Levy C; Hardouin A; Rieux C; Heutte N; Ségura C; Collet F; Allouache D; Switsers O; Delcambre C; Delozier T; Henry-Amar M; Joly F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):795-803. PubMed ID: 20888704
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
Park JH; Bae SH; Jung YS; Jung YM
J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
[TBL] [Abstract][Full Text] [Related]
16. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
[TBL] [Abstract][Full Text] [Related]
17. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
18. Cognitive-behavioral management of chemotherapy-related cognitive change.
Ferguson RJ; Ahles TA; Saykin AJ; McDonald BC; Furstenberg CT; Cole BF; Mott LA
Psychooncology; 2007 Aug; 16(8):772-7. PubMed ID: 17152119
[TBL] [Abstract][Full Text] [Related]
19. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
[TBL] [Abstract][Full Text] [Related]
20. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]